Dr. James Coates

Fellow, Ending Bioweapons Program

Dr. James Coates is the Health and Human Performance principal at Decisive Point, a venture capital and strategic advisory firm that invests in and supports startups with emerging defense technologies. Previously, James worked at Bain Capital Life Sciences and was a research fellow at Harvard Medical School and Massachusetts General Hospital. He’s worked with small and medium-sized biotechnology startups on a wide range of strategic challenges. He graduated from McGill University in Chemical & Biomedical Engineering, received an M.Sc. in Nuclear Medicine & Medical Oncology (with honors) from the University of Oxford, and a Ph.D. in Cancer Drug Discovery also from Oxford.